1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
34.86%
Revenue growth at 50-75% of CSIQ's 61.28%. Martin Whitman would worry about competitiveness or product relevance.
28.91%
Gross profit growth under 50% of CSIQ's 156.73%. Michael Burry would be concerned about a severe competitive disadvantage.
151.45%
EBIT growth above 1.5x CSIQ's 75.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
151.45%
Operating income growth above 1.5x CSIQ's 75.66%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
257.74%
Net income growth above 1.5x CSIQ's 118.18%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
254.71%
EPS growth above 1.5x CSIQ's 118.18%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
240.65%
Diluted EPS growth above 1.5x CSIQ's 118.18%. David Dodd would see if there's a robust moat protecting these shareholder gains.
3.42%
Share count expansion well above CSIQ's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
9.97%
Diluted share count expanding well above CSIQ's 0.51%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-371.63%
Negative OCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-70.65%
Negative FCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41.51%
AR growth well above CSIQ's 24.03%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.82%
Inventory is declining while CSIQ stands at 10.28%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
38.41%
Asset growth above 1.5x CSIQ's 23.74%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
25.38%
BV/share growth above 1.5x CSIQ's 3.43%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
112.50%
Debt growth far above CSIQ's 63.63%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
38.32%
R&D growth drastically higher vs. CSIQ's 40.69%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
6.12%
SG&A declining or stable vs. CSIQ's 33.25%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.